glp-1 ban Novo pressures compounders as FDA takes hold GLP-1 Medications for Weight Loss:

The inherent slowed emptying from gastroparesis combined with the deliberate slowing caused by the medication dramatically increases the risk of bezoars

For instance, some patients might benefit from a lower dose to minimize side effects, while others may need a higher dose for optimal results

Our all-in pricing covers medication, consultations, and ongoing support from your entire Fella Team

Fiber breakdown: Gut bacteria break down fiber into short-chain fatty acids (SCFAs)

The bloating experienced isnt just from slower stomach emptying

Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans